MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 35, Issue 3, Pages 1077-1086
Publisher
Wiley
Online
2014-07-10
DOI
10.1111/liv.12636
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer
- (2014) Kenji Takahashi et al. FEBS Open Bio
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
- (2013) E Mogilyansky et al. CELL DEATH AND DIFFERENTIATION
- New Data Supporting Modified RECIST (mRECIST) for Hepatocellular Carcinoma
- (2013) R. Lencioni CLINICAL CANCER RESEARCH
- Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
- (2013) Gianpiero Di Leva et al. PLoS Genetics
- Beyond KRAS mutation status: influence of KRAScopy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
- (2012) Leonie JM Mekenkamp et al. BMC CANCER
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- MicroRNAs in Liver Disease
- (2012) Xin Wei Wang et al. GASTROENTEROLOGY
- MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
- (2012) Silvia Giordano et al. HEPATOLOGY
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
- (2012) Tokuzo Arao et al. HEPATOLOGY
- Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
- (2012) Nicola Personeni et al. JOURNAL OF HEPATOLOGY
- Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
- (2012) Florie Borel et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
- (2012) Na Liu et al. LANCET ONCOLOGY
- microRNAs in cancer management
- (2012) Yi W Kong et al. LANCET ONCOLOGY
- MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma
- (2012) Claudia Augello et al. LIVER INTERNATIONAL
- DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways
- (2012) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer
- (2012) Qifeng Wang et al. PLoS One
- Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
- (2011) Julien Edeline et al. CANCER
- MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
- (2011) M. Preis et al. CLINICAL CANCER RESEARCH
- microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma
- (2011) Changchun Zhou et al. FEBS LETTERS
- MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
- (2011) Sara Toffanin et al. GASTROENTEROLOGY
- MicroRNA therapeutics in preclinical cancer models
- (2011) Minlee Kim et al. LANCET ONCOLOGY
- A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
- (2011) Trupti Paranjape et al. LANCET ONCOLOGY
- miR-296 regulation of a cell polarity–cell plasticity module controls tumor progression
- (2011) V Vaira et al. ONCOGENE
- Induction of DNA Damage-Inducible Gene GADD45 Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
- (2010) D.-L. Ou et al. CANCER RESEARCH
- New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers
- (2010) A. Villanueva et al. CLINICAL CANCER RESEARCH
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
- (2010) Hua Zhao et al. PLoS One
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma
- (2009) Claudia Augello et al. BMC CANCER
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
- (2009) Shoumei Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
- (2009) Junfang Ji et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
- (2008) K Oikonomopoulou et al. BRITISH JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started